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wThere is something fascinating about science.
One gets such wholesale returns of conjecture
out of such a trifling investment of fact.
—Mark Twain (1)
T
his issue of iJACC presents 2 research re-
ports that employ image analysis methods
or functional studies as an adjunct to cor-
onary computed tomography (CT) an-
iography in order to improve its performance.
o et al. (2) evaluated symptomatic patients with
uspected coronary artery disease at intermediate
isk. All patients underwent coronary CT angiog-
aphy and a relatively new method of stress CT
yocardial perfusion imaging in addition to inva-
ive coronary angiography and fractional flow re-
erve (FFR) measured in all 3 coronary arteries.
hey demonstrated that the addition of myocar-
ial perfusion imaging to coronary CT angiogra-
hy improved the specificity of CT for the detec-
ion of hemodynamically significant stenoses,
rom 68% to 95% on a per-patient level. On the
ther hand, Yoon et al. (3) studied patients with
nown or suspected coronary artery disease with
oronary CT angiography and CT-based func-
ional assessment of lesion severity prior to inva-
ive catheterization and invasive FFR measure-
ent. CT angiography, which by itself had a
ensitivity and specificity of 71% and 68%, respec-
ively, for the identification of invasively-verified
oronary lesions of FFR 0.8, was not improved by
he CT assessment of transluminal attenuation gra-
ient, but improved substantially by determination
f CT-based FFR calculation with sensitivity and
pecificity increasing to 81% and 94%, respectively.
e have chosen to highlight a paper with some
*From the Medizinische Klinik I, Universitätsklinikum Gießen und Mar-t
burg, Gießen, Germany; †University of Minnesota, Minneapolis, Minne-
sota; and the ‡Mount Sinai School of Medicine, New York, New York.rominent negative findings along with a positive
ne since these 2 papers illustrate why every new
echnology needs to be evaluated and understood
ithin the ambit of proper perspective and clear
crutiny.
It is not surprising to see that papers that re-
ort on new imaging methods often convey the
essage that the new tools improve test perfor-
ance over what has been available previously.
ublication bias makes it more likely that manu-
cripts with positive test results are submitted
nd published, and those with negative results
re less frequently encountered— often the file
abinet phenomenon where negative reports are
led away since there is a widespread percep-
ion that a high-quality journal will not publish
egative reports. As editors of JACC: Cardiovascu-
ar Imaging, we have not been averse to publish-
ng a paper with a negative result, as long as the
uality of investigation is high and comes with an
mportant message. Consistent with this, publication
ias has been shown to be predominantly investiga-
or-related and less so due to the editorial exclusions
4). What is the role of negative papers and how
oes excluding them affect the corpus of knowledge?
ublication bias is a serious issue that cannot be un-
erestimated. Therapeutic or diagnostic guidelines
re typically based on published study results, and
npublished negative experiences remain unnoticed
nd thus do not contribute to refining guidelines.
urthermore, negative results remain underrepre-
ented in pooled and meta-analyses for lack of pub-
ic availability of the data that again detracts from
heir veracity. This has the risk of seriously biasing
ur understanding of the truth. The harm goes even
urther. Other investigators might spend a lot of
ime, effort, and money trying to replicate findings
ithout knowing that this has already been showno be nonreplicable. Finally, this also entails an op-
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hance of chasing more fruitful avenues.
There is currently no mechanism to regularly
showcase negative studies. Some authors have ar-
gued that studies showing positive results must be
examined more critically (5), and that a high den-
sity of positive studies with low pre-study odds
makes it more likely that the original hypothesis
may be suspect (6). It is also claimed that the
positive studies often have a poor track record for
replication in later efforts (7). A systematic way to
encourage publication of convincing, high-impact
negative studies is mandatory. Clinical trialists have
realized this and are requiring documentation of
negative trials. Journals have been slow to embrace
this, out of a zeal to be the first to report positive
findings and also probably for fear of risking low ci-
tation impact. Editorial willingness is probably a
good first step to reduce the froth of positive stud-
ies. We at iJACC have never discouraged high-im-
pact negative papers where it is likely to provide a
balanced perspective of the field.
These 2 papers also raise another interesting is-
sue that one should keep in mind when thinking
about cutting edge papers in new areas of imaging
technology. It is being observed frequently that
the standard of reference against which a new
method is compared, over time performs less im-
pressively than initially reported. While it is easy
to dismiss this as methodological imperfection, we
tend to believe that the passage of time and mul-
tiple replications makes the results more realistic
and closer to the truth. With respect to the 2
studies mentioned above, the results of anatomic
coronary CT angiography, at least in the study
published by Yoon et al. (3), performed rather
poorly (sensitivity 71%; specificity 68%) compared
to previous trials of coronary CT angiography
with commonly reported sensitivity neighboring
95% (8,9). While this may partly be due to the
use of different validation methods, such as FFR
or anatomy-based coronary angiography, it is not
an uncommon observation that methods may per-
form differently when first described, confirmed in
larger studies, validated in multicenter trials, or
used as a reference for comparison purposes.
There are many other examples of this phe-
nomenon, even in studies done in expert hands.
In an initial study of noninvasive, CT-based FFRmeasurement of 103 patients, when the method
was first presented, per-patient sensitivity was
93% (95% confidence interval [CI]: 82% to 98%)
and specificity was 82% (95% CI: 68% to 91%) as
compared to invasively measured FRR (10). In a
larger follow-up trial of 252 patients published a
few weeks ago, per-patient sensitivity was only
slightly lower at 90% (95% CI: 84% to 95%) but
specificity decreased substantially to 54% (95%
CI: 46% to 83%) (11). Lower specificity damp-
ened the enthusiasm for the method when the
trial was presented recently at the European Soci-
ety of Cardiology meeting. In 1993, one of the
first publications on coronary magnetic resonance
(MR) angiography reported a diagnostic accuracy
of more than 90% for the identification of 50%
diameter coronary stenosis in a small group of in-
dividuals (12). Since then, such good results have
only infrequently been reported and in the 2 most
recent trials (13,14), diagnostic performance has
been demonstrated to be substantially lower. It is
conceivable that, in spite of best intentions, more
suitable patients are approached for an initial
evaluation of a new method, test, or therapy while
the common garden variety of patients are in-
cluded only at a later stage when publication suc-
cess depends on a sound study design. This, in
fact, may have been the reason for lower accuracy
in the second trial of CT-based FFR as compared
to the first, with possibly less robust image quality
accepted for the larger-follow up trial. Also, when
a new method is first described, it is likely to be
from the hands of experts in the field who are
aware of all intricacies, and put more effort into
patient selection, data acquisition, and interpreta-
tion. Another corollary of this is that results also
tend to deteriorate when a given method em-
ployed as a comparator is subsequently analyzed
by experts in another methodology. The experi-
ence of 2 research groups in Berlin serves as a
miniature field study to highlight this finding. In
a comparative trial of MR and CT coronary an-
giography, performed by 1 group with substantial
experience in MR (but lesser CT expertise), CT
demonstrated only a marginally superior accuracy
for the detection of stenosis (sensitivity 90%;
specificity 83%) compared to magnetic resonance
imaging (MRI) (87% and 77%, respectively) (15).
In the trial performed by a competing research
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1189group with expertise in cardiac CT in the same
city, CT outperformed MRI (sensitivity 82% vs.
54% and specificity 90% vs. 87%) (16). A promi-
nent example of this effect is the CE-MARC
(Clinical Evaluation of Magnetic Resonance Im-
aging in Coronary Heart Disease) trial, in which
a comprehensive multiparametric MRI study,
(consisting of perfusion, late enhancement, left
ventricular function assessment, and coronary im-
aging) was compared to single-photon emission
computed tomography (SPECT) myocardial per-
fusion for the ability to identify patients with cor-
onary stenosis found on invasive angiography
(17). MRI, with a sensitivity of 87% and specific-
ity of 83%, was substantially superior to SPECT
(67% and 83%, respectively), but the trial was
criticized for having been performed by MR ex-to where. PLoS Clin Trial 2006;
1:e36.
1
1
12. Manning WJ, Li W
preliminary reportThese seem obvious points, but are commonly
overlooked when analyzing and interpreting new
studies. Any study that assesses a given test needs
to be interpreted in the context in which it was
performed. And as methods mature, results will in
most instances, turn out to be less impressive than
reported in the first few publications—initially
positive results always need to stand the test of
time and demonstrate reproducibility. In future, a
high replication index, more than an arbitrary p
value, might become a litmus test of how true and
durable a result is will be! It is important for the
readers to see both positive and negative trial re-
sults to get a complete picture. So here is a first
step from our side— show us your highest-quality
negative studies, and we promise to provide you a
stage for at least some of those high-impact arti-perts with very little experience in SPECT. cles in JACC: Cardiovascular Imaging.R E F E R E N C E S
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